In the November Journal Club episode, Dr. Oliver Medvedik reviews a study by a research team that includes Professor George Church
In this study, adenoassociated viruses were used to deliver a multi-target gene therapy that targeted 3 longevity genes. In mouse models, the focus was on mitigating T2 Diabetes, Heart Failure, and Kidney Failure. Positive results were observed. Livestream will be available on Facebook on Tuesday 26th November at 1pm EDT.
Source:
